for patients with cutaneous t cell lymphoma ( ctcl ) ( mycosis fungoides and the sezary syndrome ) , a response rate of 45 % , with 10 % complete responses , was seen in patients treated with recombinant alpha-interferon at the national cancer institute ( nci ) .
C0079773
cutaneous t cell lymphoma
C0036920
sezary syndrome